Economy|HealthTrump unveils healthcare plan without clear funding or execution timelineTrump’s healthcare plan promises lower costs but lacks specifics and faces challenges from a divided Congress.
On Thu, Dec 19, 2025, the Trump administration unveiled a new healthcare plan aiming to replace government subsidies for insurance with direct payments into health savings accounts. This initiative is intended to improve price transparency, foster…
On Thu, Dec 19, 2025, the Trump administration unveiled a new healthcare plan aiming to replace government subsidies for insurance with direct payments into health savings accounts. This initiative is intended to improve price transparency, foster competition, and minimize the necessity for doctor visits.
The plan includes an insurance cost-sharing reduction program that may reduce premiums for common plans by over 10%. It mandates pharmacy benefit managers and insurers to disclose profits from premiums and denial frequencies. Providers and insurers accepting Medicare or Medicaid funds must publish pricing and fees. Companies must make rate and coverage comparisons accessible on their websites in plain language.
Framework and Legislative Implications
The plan, referred to as "The Great Healthcare Plan," is intended as a framework to guide Congressional legislation. However, details such as the amount and eligibility for direct payments remain unspecified. The plan excludes provisions for extending existing subsidies.
This initiative is intended to improve price transparency, foster competition, and minimize the necessity for doctor visits.
Average premium costs are projected to increase significantly, with estimates rising to $1,904 in 2026 from $888 in 2025. Discussions on reinstating expired tax credits continue, but bipartisan consensus is uncertain.
Following the announcement, healthcare insurance stocks showed an upward trend. UnitedHealthcare rose by 0.8%, Humana by 3.5%, and Oscar Health by 6.4%. Conversely, pharmaceutical stocks such as Eli Lilly and AbbVie experienced declines.
The Trump administration emphasizes direct consumer funding over insurer subsidies, a stance aligned with Republican Congressional views. The White House has yet to provide a timeline for implementation.
Based on reporting by Al Jazeera.
